Cargando…

Evaluation of Cause of Deaths' Validity Using Outcome Measures from a Prospective, Population Based Cohort Study in Tehran, Iran

OBJECTIVE: The aim of this study was to evaluate the validity of cause of death stated in death certificates in Tehran using outcome measures of the Tehran Lipid and Glucose Study (TLGS), an ongoing prospective cohort study. METHODS: The cohort was established in 1999 in a population of 15005 people...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khalili, Davood, Mosavi-Jarrahi, Alireza, Eskandari, Fatemeh, Mousavi-Jarrahi, Yasaman, Hadaegh, Farzad, Mohagheghi, Mohammadali, Azizi, Fereidoun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280301/ https://www.ncbi.nlm.nih.gov/pubmed/22355365 http://dx.doi.org/10.1371/journal.pone.0031427

Ejemplares similares

Estimating the incidence of lung cancer attributable to occupational exposure in Iran
por: Mosavi-Jarrahi, Alireza, et al.
Publicado: (2009)

Temporal analysis of the incidence of meningitis in the Tehran metropolitan area, 1999-2005
por: Mosavi-Jarrahi, Alireza, et al.
Publicado: (2009)

Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study
por: Sardarinia, Mahsa, et al.
Publicado: (2021)

Sudden cardiac death among Iranian population: a two decades follow-up of Tehran lipid and glucose study
por: Toreyhi, Hossein, et al.
Publicado: (2021)

Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012–2015
por: Asgari, Samaneh, et al.
Publicado: (2019)

Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2021)

The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study
por: Hadaegh, Farzad, et al.
Publicado: (2021)

Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study
por: Asgari, Samaneh, et al.
Publicado: (2022)

Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2016)

Outcomes of a Longitudinal Population-based Cohort Study and Pragmatic Community Trial: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Khalili, Davood, et al.
Publicado: (2018)

Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2018)

Underestimating the Effect of Lipids on Cardiovascular Events: Regression Dilution Bias in the Population-Based Cohort of Tehran Lipid and Glucose Study
por: Masudi, Sima, et al.
Publicado: (2015)

External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population
por: Asgari, Samaneh, et al.
Publicado: (2020)

Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2019)

Exploring Spatial Patterns of Colorectal Cancer in Tehran City, Iran
por: Mansori, Kamyar, et al.
Publicado: (2018)

Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2016)

Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran
por: Eslami, Ali, et al.
Publicado: (2019)

External validation of the American prediction model for incident type 2 diabetes in the Iranian population
por: Asgari, Samaneh, et al.
Publicado: (2023)

12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study
por: Rabani, SeyedHossein, et al.
Publicado: (2018)

Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2018)

Sex Specific Incidence Rates of Type 2 Diabetes and Its Risk Factors over 9 Years of Follow-Up: Tehran Lipid and Glucose Study
por: Derakhshan, Arash, et al.
Publicado: (2014)

Sex specific trajectories of central adiposity, lipid indices, and glucose level with incident hypertension: 12 years Follow-up in Tehran lipid and glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2021)

Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran
por: Fahimfar, Noushin, et al.
Publicado: (2012)

The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study
por: Rasooli, Rahele, et al.
Publicado: (2022)

Prognostic significance of the Complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study
por: Mohammadreza, Bozorgmanesh, et al.
Publicado: (2012)

Spatial Inequalities in the Incidence of Colorectal Cancer and Associated Factors in the Neighborhoods of Tehran, Iran: Bayesian Spatial Models
por: Mansori, Kamyar, et al.
Publicado: (2018)

The Incidence of Coronary Heart Disease and the Population Attributable Fraction of Its Risk Factors in Tehran: A 10-Year Population-Based Cohort Study
por: Khalili, Davood, et al.
Publicado: (2014)

Validation of the Framingham hypertension risk score in a middle eastern population: Tehran lipid and glucose study (TLGS)
por: Koohi, Fatemeh, et al.
Publicado: (2021)

Risk of Coronary Heart Events Based on Rose Angina Questionnaire and ECG Besides Diabetes and Other Metabolic Risk Factors: Results of a 10-Year Follow-up in Tehran Lipid and Glucose Study
por: Mansournia, Mohammad Ali, et al.
Publicado: (2017)

Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2020)

Correction To: Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2020)

Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study
por: Moazzeni, Seyyed Saeed, et al.
Publicado: (2021)

Determining the Factors Associated with Cardiovascular Disease Recurrence: Tehran Lipid and Glucose Study
por: Taravatmanesh, Samira, et al.
Publicado: (2017)

Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2010)

Beta-Cell Age Calculator, a Translational Yardstick to Communicate Diabetes Risk with Patients: Tehran Lipid and Glucose Study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2012)

Asian Pacific Journal of Cancer Prevention and Challenges Facing in its 18th Year of Publishing
por: Jarrahi, Alireza Mosavi
Publicado: (2017)

Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study
por: Khajavi, Alireza, et al.
Publicado: (2021)

Sex specific impact of different obesity phenotypes on the risk of incident hypertension: Tehran lipid and glucose study
por: Kabootari, Maryam, et al.
Publicado: (2019)

Sex differences in the association between diabetes and hypertension and the risk of stroke: cohort of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2022)

Trends in cardiovascular risk factors in diabetic patients in comparison to general population in Iran: findings from National Surveys 2007–2016
por: Malekzadeh, Hamid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t6hcobksh7ut04qoes3dukih02